4 Biotech Stocks With Big Catalysts in September
The biopharmaceutical industry has been exploding, with roughly one new initial public offering every week. There are so many drug developers out there, new and old, that it can be tough to spot the ones about to soar or crash.
You could try watching the sky for a shooting star, but that really isn't necessary. Here's what you need to know about two presentations planned for the 2019 World Conference on Lung Cancer and their far-ranging effects on these four companies.
$3.7 billion
Source Fool.com
